takeda.com

Website review takeda.com

Takeda Pharmaceuticals: Global Homepage

 Generated on March 04 2026 10:15 AM

Old data? UPDATE !

The score is 53/100

SEO Content

Title

Takeda Pharmaceuticals: Global Homepage

Length : 39

Perfect, your title contains between 10 and 70 characters.

Description

Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

Length : 131

Great, your meta description contains between 70 and 160 characters.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
title Takeda Pharmaceuticals: Global Homepage
description Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
url https://www.takeda.com/
locale en
image http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
image:secure_url https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
image:width 1200
image:height 627
image:type image
image:alt Takeda Pharmaceuticals: Global Homepage
type website

Headings

H1 H2 H3 H4 H5 H6
1 5 14 0 0 0
  • [H1] Takeda Pharmaceuticals: Global Homepage
  • [H2] Expanding access to hereditary angioedema care in Vietnam
  • [H2] Recent News
  • [H2] Better Health, Brighter Future
  • [H2] Our Areas of Focus
  • [H2] Sign up for investors newsletter
  • [H3] Takeda - Global
  • [H3] Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
  • [H3] Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
  • [H3] U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
  • [H3] Takeda Reports Third-Quarter FY2025 Results – Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind – Progressing Toward Three Transformative Launches Ahead
  • [H3] Join Us
  • [H3] Investors
  • [H3] R&D
  • [H3] Gastrointestinal and Inflammation
  • [H3] Rare Diseases
  • [H3] Plasma-Derived Therapies
  • [H3] Oncology
  • [H3] Neuroscience
  • [H3] Vaccines

Images

We found 6 images on this web page.

Good, most or all of your images have alt attributes.

Text/HTML Ratio

Ratio : 2%

This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Great, there are no Iframes detected on this page.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

Perfect! No underscores detected in your URLs.

In-page links

We found a total of 134 links including 0 link(s) to files

Anchor Type Juice
Our Company Internal Passing Juice
Leadership Internal Passing Juice
Sustainability Approach Internal Passing Juice
Access to Medicines Internal Passing Juice
Sustainability Disclosures Internal Passing Juice
Ethics Internal Passing Juice
Transparency Disclosures Internal Passing Juice
Positions Internal Passing Juice
Corporate Giving Internal Passing Juice
Governance Strategy Internal Passing Juice
Governance Structure Internal Passing Juice
Charters and Reports Internal Passing Juice
Areas of Focus Internal Passing Juice
Research and Development Internal Passing Juice
Pipeline Internal Passing Juice
Our Products Internal Passing Juice
Manufacturing Internal Passing Juice
Suppliers Internal Passing Juice
Clinical Trials Internal Passing Juice
Our Stories Internal Passing Juice
Press Releases Internal Passing Juice
Statements Internal Passing Juice
Media Resources Internal Passing Juice
Overview Internal Passing Juice
Financial Results Internal Passing Juice
Investor Events Internal Passing Juice
Investor Contact Internal Passing Juice
Careers Internal Passing Juice
Leadership Internal Passing Juice
Sustainability Approach Internal Passing Juice
Access to Medicines Internal Passing Juice
Ethics Internal Passing Juice
Corporate Giving Internal Passing Juice
Governance Structure Internal Passing Juice
Charters and Reports Internal Passing Juice
Research and Development Internal Passing Juice
Pipeline Internal Passing Juice
Our Products Internal Passing Juice
Manufacturing Internal Passing Juice
Suppliers Internal Passing Juice
Clinical Trials Internal Passing Juice
Press Releases Internal Passing Juice
Statements Internal Passing Juice
Media Resources Internal Passing Juice
Overview Internal Passing Juice
Financial Results Internal Passing Juice
Investor Events Internal Passing Juice
Investor Contact Internal Passing Juice
English Internal Passing Juice
Japanese Internal Passing Juice
English Internal Passing Juice
French Internal Passing Juice
Arabic Internal Passing Juice
Spanish Internal Passing Juice
English Internal Passing Juice
German Internal Passing Juice
Russian Internal Passing Juice
English Internal Passing Juice
French Internal Passing Juice
Dutch Internal Passing Juice
Bosnian Internal Passing Juice
Portuguese Internal Passing Juice
Bulgarian Internal Passing Juice
English Internal Passing Juice
French Internal Passing Juice
Spanish Internal Passing Juice
Chinese Internal Passing Juice
Spanish Internal Passing Juice
Croatian Internal Passing Juice
Czech Internal Passing Juice
Danish Internal Passing Juice
Spanish Internal Passing Juice
English Internal Passing Juice
Arabic Internal Passing Juice
Estonian Internal Passing Juice
Finnish Internal Passing Juice
French Internal Passing Juice
German Internal Passing Juice
Greek Internal Passing Juice
English Internal Passing Juice
Chinese Internal Passing Juice
Hungarian Internal Passing Juice
English Internal Passing Juice
Indonesian Internal Passing Juice
English Internal Passing Juice
Hebrew Internal Passing Juice
Italian Internal Passing Juice
Kazakh Internal Passing Juice
Russian Internal Passing Juice
Korean Internal Passing Juice
Latvian Internal Passing Juice
Lithuanian Internal Passing Juice
English Internal Passing Juice
Spanish Internal Passing Juice
Dutch Internal Passing Juice
English Internal Passing Juice
Norweigan Internal Passing Juice
Spanish Internal Passing Juice
English Internal Passing Juice
Polish Internal Passing Juice
Portuguese Internal Passing Juice
Romanian Internal Passing Juice
Russian Internal Passing Juice
English Internal Passing Juice
Arabic Internal Passing Juice
Serbian Internal Passing Juice
English Internal Passing Juice
Slovak Internal Passing Juice
Slovenian Internal Passing Juice
English Internal Passing Juice
Spanish Internal Passing Juice
Swedish Internal Passing Juice
German Internal Passing Juice
French Internal Passing Juice
Chinese Internal Passing Juice
Thai Internal Passing Juice
Turkish Internal Passing Juice
Ukrainian Internal Passing Juice
English Internal Passing Juice
Arabic Internal Passing Juice
English Internal Passing Juice
English Internal Passing Juice
English Internal Passing Juice
- Internal Passing Juice
Locations Internal Passing Juice
Contact us Internal Passing Juice
Careers Internal Passing Juice
Financial Highlights Internal Passing Juice
HCPs Internal Passing Juice
Patients Internal Passing Juice
Terms and Conditions Internal Passing Juice
Privacy Notice Internal Passing Juice
Cookie Policy Internal Passing Juice
Accessibility Statement Internal Passing Juice

SEO Keywords

Keywords Cloud

takeda drug english patients diseases more spanish french corporate arabic

Keywords Consistency

Keyword Content Title Keywords Description Headings
english 38
spanish 14
diseases 11
french 10
takeda 9

Usability

Url

Domain : takeda.com

Length : 10

Favicon

Great, your website has a favicon.

Printability

We could not find a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Too bad, your website has too many CSS files (more than 4).
Too bad, your website has too many JS files (more than 6).
Perfect, your website takes advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://www.takeda.com/sitemap.xml

Robots.txt

https://takeda.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Missing

We didn't detect an analytics tool installed on this website.

Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.

PageSpeed Insights


Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.